A complete list of publications can be viewed on Scopus or Google Scholar.

Editorial Highlights

1.  Referring to GREEN AC et al. (2021). Silberstein L. (2021) B cells: fed and grown in the bone. Blood. 138(4): 286-287 

‘Green et al have undertaken an impressive effort to address the challenge of [microenvironment control] within B lymphopoiesis. Their prospective isolation strategy revealed a previously unrecognized functional heterogeneity within murine skeletal cells… This will create new opportunities for selectively manipulating specific hematopoietic subsets and enable design of precision therapies for hematopoietic regeneration and blood cancers.’

2.  Referring to Bonagas et al. (2022). Dionellis VS & Halazonetis TD. (2022) Beating cancer one carbon at a time. Nature Cancer. 3: 141-142 

3.  Referring to Paton-Hough et al. (2019). Calvi LM & Hofbauer LC. (2019) A novel strategy for repairing myeloma bone lesions: lessons from murine models. J Bone Mineral Research. 34(5):781-782 

Journal articles

1. GREEN AC, Marttila P, Kiweler N, Chalkiadaki C, Wiita E, Cookson V, Long M, Lesur A, Eiden K, Bernardin F, Vallin KSA, Borhade A, Long M, Ghahe EK, Jimnénez-Alonso JJ, Jemth AS, Loseva O, Mortusewicz O, Meyers M, Viry E, Johansson AI, Hodek O, Homan E, Bonagas N, Ramos L, Sandberg L, Fröden M, Moussay E, Slipicevic A, Letellier E, Paggetti J, Sørenson CS, Helleday T, Henriksson M, Meiser J. Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells. Nature Metabolism. 

2. Dadzie TG, GREEN AC. (2022) The role of the bone microenvironment in regulating myeloma residual disease and treatment. Frontiers in Oncology

3. Bongagas N, Gustafsson NMS, Henriksson M, Marttila P, Gustafsson R, Wiita E, Borhade S, GREEN AC, Vallin K, Sarno A, Svensson R, Gokturk C, Pham T, Jemth AS, Loseva, Cookson V, Kiweler N, Sandberg L, Rasti A, Unterlass JE, Haraldsson M, Andersson Y, Scaletti ER, Bengtsson C, Paulin CBJ, Sanjiv K, Abdurakhmanov E, Pudelko L, Kunz B, Desroses M, Iliev P, Färnegårdh K, Krämer A, Garg N, Michel M, Häggblad Sahlberg S, Jarvius M, Kalderén C, Bögedahl Jensen A, Almlöf I, Karsten S, Zhang SM, Häggblad M, Eriksson A, Liu J, Glinghammar B, Nekhotiaeva N, Klingegård F, Koolmeister T, Martens U, Llona-Minguez S, Moulson R, Nordström H, Parrow V, Dahllund L, Sjöberg B, Vargas IL, Vo D, Wannberg J, Knapp S, Krokan H, Arvidsson P, Scobie M, Meiser J, Stenmark P, Warpman Berglund U, Homan E, Helleday T. (2022) Pharmacological targeting MTHFD2 supresses acute myeloid leukemia by thymidine depletion and replication stress. Nature Cancer. 3: 156-172 

4. Trivanović D, Tencerova M, Herrmann M, GREEN AC, Milovanović P. (2022) Mediators of Inflammation in Bone Physiology and Disease. Mediators of Inflammation. 2022:9767408 

5. GREEN AC, Tjin G, Lee S, Chalk AM, Staszkowski L, Kwang D, Kimura, T, Wu J, Purton LE. (2021) The characterization of four distinct populations of murine skeletal niche cells that have different roles in B lymphopoiesis. Blood. 138(4):304-317 

6. GREEN AC* (corresponding author), Lath D, Hudson K, Walkley B, Down JM, Owen R, Evans HR, Paton-Hough J, Reilly G, Lawson MA, Chantry AD. (2019) TGF-β inhibition promotes collagen maturation to enhance bone repair and fracture resistance in multiple myeloma. J Bone Mineral Research. 34:2311-2326

7. Paton-Hough J, Tazzyman S, Evans HR, Lath D, Down JM, GREEN AC, Chantry AD, Lawson MA. (2019) Preventing and repairing myeloma bone disease by combining conventional antiresorptive treatment with a bone anabolic. J Bone Mineral Research. 34(5): 783-796 

8. Thai J, GREEN AC, Stamp L, Spencer NJ, Purton LE, Ivanusic J. (2019) A population of non-neuronal GFRα3-expressing cells in bone marrow resembles non-myelinating Schwann cells. Cell and Tissue Research. 378(3): 441-456 

9. GREEN AC*, Rudolph-Stringer V, Chantry AD, Wu J*, Purton LE*. (2019) Mesenchymal lineage cells and their importance in B lymphocyte niches. Bone. 119:42-56

10. GREEN AC, Rudolph-Stringer V, Straszkowski L, Tjin G, Crimeen-Irwin B, Walia MK, Sims, NA, Martin TJ, Purton LE. (2018) Retinoic Acid Receptor γ Activity in Mesenchymal Stem Cells Regulates Endochondral Bone, Angiogenesis and B Lymphopoiesis. J Bone Mineral Res. 33(12): 2202-2213

11. Joseph C*, GREEN AC* (co-first), Kwang D, Purton LE. (2018) Extrinsic regulation of hematopoietic stem cells and lymphocytes by vitamin A. Curr Stem Cell Rep. 4(4) 282-290 

12. GREEN AC, Kocovski P, Jovic, T, Walia MK, Chandraratna RAS, Martin TJ, Baker EK, Purton LE. (2017) Retinoic acid receptor signalling directly regulates osteoblast and adipocyte differentiation from mesenchymal progenitor cells. Exp Cell Res. 350 (1): 284-297 

13. Joseph C, Nota C, Fletcher JL, Maluenda AC, GREEN AC, Purton LE. (2016) Retinoic Acid Receptor y Regulates B and T Lymphopoiesis via Nestin-Expressing Cells in the Bone Marrow and Thymic Microenvironments. J Immunology 196(5):2132-44

14. GREEN AC* (corresponding author), Martin TJ, Purton LE. (2016) The role of vitamin A and retinoic acid receptor signaling in post-natal maintenance of bone. J Steroid Biochem Mol Biol. 155(Pt A): 135-46

15. GREEN AC, Poulton IJ, Vrahnas C, Häusler KD, Walkley CR, Wu JY, Martin TJ, Gillespie MT, Chandraratna RA, Quinn JM, Sims NA, Purton LE. (2015) RARγ is a negative regulator of osteoclastogenesis. J Steroid Biochem Mol Biol. 150:46-53

16. Baker EK, Taylor S, Gupte A, Chalk AM, Bhattacharya S, Green AC, Martin TJ, Strbenac D, Robinson MD, Purton LE, Walkley CR. (2015) Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma Bone. 73:223-32.

Invited Book chapters

1. GREEN AC, Andrews RE, Lawson MA. (2020) The role of the osteoclast in cancer. Encyclopedia of Bone Biology. 180-200. Elsevier 2020

Peer reviewed articles in conference proceedings

1. Zhu Y, GREEN AC, Guo L, Evans HR, Mihaylova L. Machine Learning Approaches for Cancer Bone Segmentation from Micro Computed Tomography Images. 2020 IEEE 23rd International Conference on Information Fusion (FUSION), 06 Jul 2020 - 09 Jul 2020. Rustenburg, South Africa, 2020, pp. 1-6 doi.org/10.23919/FUSION45008.2020.9190495 

Selected Invited Lectures

1. GREEN AC. (2023) Mouse models of myeloma dormancy to study bone cross-talk. European Calcified Tissue Society (ECTS) and Bone Research Society (BRS) Joint Meeting, Liverpool, UK 2023

2. GREEN AC. (2022) Targeting the bone microenvironment in myeloma. ECTS Congress, Helsinki, Finland. May 2022

3. GREEN AC. (2022) Targeting osteoblasts enhances Karonudib toxicity in myeloma. AIMM-ASBMR Meeting, Snowmass, Colorado, USA. April 2022

4. GREEN AC. (2014) Retinoic acid receptor regulation of bone and haematopoiesis and FACS isolation of osteoblasts. Stanford University, CA, USA. May 2014

5. GREEN AC. (2011) Inhibition of Retinoic Acid Receptor (RAR) Signalling Potentiates Osteoblast Differentiation and Bone Formation. Mellanby Centre for Bone Research, Sheffield, UK.